{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:34:27Z","timestamp":1794864867259,"version":"4.9.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The innovation of a therapeutic agent with dual anti-inflammatory, anticancer and reversing the dynamic of microtubules like colchicine was crucial. VEGFR2 inhibition has been established as a therapeutic approach for managing cancer, the colchicine site, situated on \u00df-tubulin and \u03b1-tubulin was also considered in cancer development, and metastasis. Moreover, uncontrolled inflammation predisposes to pleiotropic effects leading to cancer development and promoting all stages of tumorigenesis. A polymeric state of a novel one-dimensional palladium-based metal-organic framework (1D Pd-MOF), resulting from the coordination of pyrazine with palladium nuclei to achieve the more pronounced effect of polynuclear characteristics of palladium compared to mononuclear compounds, was designed, synthesized, and screened for its anticancer activity against the A549 lung cancer cell line, with comparison to normal cells. The characterization was performed using different techniques and supported by DFT investigations. The 1D Pd MOF exhibited a potent cytotoxic effect, with an IC\n                    <jats:sub>50<\/jats:sub>\n                    value of 78.21\u2009\u00b1\u20090.41\u00a0\u00b5g\/mL against the A549 lung cancer cell line, while showing minimal toxicity toward the normal WI-38 cell line. To investigate the inhibitory activity of the 1D Pd-MOF towards VEGFR2 kinase and to confirm itseffective molecular target, VEGFR2 kinase inhibition was evaluated. The results demonstrated promising VEGFR2 inhibitory activity with a moderate IC\n                    <jats:sub>50<\/jats:sub>\n                    value of 0.658\u2009\u00b1\u20090.023\u00a0\u00b5g\/mL, compared with an IC\n                    <jats:sub>50<\/jats:sub>\n                    value of 0.079\u2009\u00b1\u20090.003\u00a0\u00b5g\/mL for sorafenib, the reference drug. This activity was further supported by significant inhibition of VEGFR2 gene expression and protein levels compared with untreated control cells. Our results revealed that 1D Pd-MOF is a promising tubulin-interacting compound, as it binds to the colchicine-binding site on tubulin and competes with colchicine in vitro, with an IC\n                    <jats:sub>50<\/jats:sub>\n                    value of 3.350\u2009\u00b1\u20090.21\u00a0\u00b5g\/mL. These findings confirm tubulin as a molecular target of the 1D Pd-MOF and support its observed cytotoxic activity. Furthermore, the 1D Pd-MOF significantly upregulated the expression levels of BAX, P53, and caspase-3 genes, while downregulating CDK4, cyclin D1, and BCL2 genes relative to the control group, suggesting growth inhibition and induction of apoptosis in treated lung carcinoma cells. These findings confirm that the 1D Pd-MOF exerts a clear anticancer effect by triggering programmed cell death through apoptosis. In addition, treatment with the 1D Pd-MOF resulted in substantial accumulation of cells in the sub-G1 fraction, accompanied by a corresponding reduction in the G2\/M phase, indicating that its cytotoxic efficacy is primarily mediated through apoptosis induction rather than cell cycle arrest at a specific checkpoint. The anti-inflammatory activity of the 1D Pd-MOF was established by its inhibition of nitric oxide (NO) production in LPS-stimulated RAW cells. Molecular docking studies showed good agreement with the experimental biological findings.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-63591-z","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:05:12Z","timestamp":1785427512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["One-dimensional palladium MOF as VEGFR2 and colchicine binding inhibitors with potential anticancer and anti-inflammatory activities: synthesis and molecular investigation"],"prefix":"10.1038","volume":"16","author":[{"given":"Heba K.","family":"Abdelhakim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safaa S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"63591_CR1","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00044-021-02765-y","volume":"30","author":"YA Ammar","year":"2021","unstructured":"Ammar, Y. A. et al. Carboxamide appended quinoline moieties as potential anti-proliferative agents, apoptotic inducers and Pim-1 kinase inhibitors. Med. Chem. Res. 30, 1649\u20131668 (2021).","journal-title":"Med. Chem. Res."},{"issue":"4","key":"63591_CR2","doi-asserted-by":"publisher","first-page":"a006098","DOI":"10.1101\/cshperspect.a006098","volume":"5","author":"R Sever","year":"2015","unstructured":"Sever, R. & Brugge, J. S. Signal transduction in cancer. Cold Spring Harb Perspect. Med. 5 (4), a006098 (2015).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"3","key":"63591_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh, R., Letai, A. & Sarosiek, K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. cell. Biol. 20 (3), 175\u2013193 (2019).","journal-title":"Nat. Rev. Mol. cell. Biol."},{"issue":"7","key":"63591_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro, B. A. & El-Deiry, W. S. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 17 (7), 395\u2013417 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"63591_CR5","doi-asserted-by":"publisher","first-page":"104053","DOI":"10.1016\/j.bioorg.2020.104053","volume":"102","author":"EM Husseiny","year":"2020","unstructured":"Husseiny, E. M. Synthesis, cytotoxicity of some pyrazoles and pyrazolo [1, 5-a] pyrimidines bearing benzothiazole moiety and investigation of their mechanism of action. Bioorg. Chem. 102, 104053 (2020).","journal-title":"Bioorg. Chem."},{"key":"63591_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-015-0204-2","volume":"15","author":"MH Naseri","year":"2015","unstructured":"Naseri, M. H. et al. Up regulation of Bax and down regulation of Bcl2 during 3-NC mediated apoptosis in human cancer cells. Cancer Cell. Int. 15, 1\u20139 (2015).","journal-title":"Cancer Cell. Int."},{"key":"63591_CR7","doi-asserted-by":"publisher","first-page":"105762","DOI":"10.1016\/j.bioorg.2022.105762","volume":"123","author":"EM Othman","year":"2022","unstructured":"Othman, E. M., Fayed, E. A., Husseiny, E. M. & Abulkhair, H. S. Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1, 2, 3-triazole-chalcone conjugates. Bioorg. Chem. 123, 105762 (2022).","journal-title":"Bioorg. Chem."},{"issue":"4","key":"63591_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.intimp.2008.11.020","volume":"9","author":"YL Ge","year":"2009","unstructured":"Ge, Y. L., Zhang, X., Zhang, J. Y., Hou, L. & Tian, R. H. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells. Int. Immunopharmacol. 9 (4), 389\u2013395 (2009).","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"63591_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G. & Jain, R. K. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat. Rev. Clin. Oncol. 15 (5), 325\u2013340 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"63591_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/157489207779561426","volume":"2","author":"A Veeravagu","year":"2007","unstructured":"Veeravagu, A. et al. Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy. Recent. Pat. Anticancer Drug Discov. 2 (1), 59\u201371 (2007).","journal-title":"Recent. Pat. Anticancer Drug Discov"},{"key":"63591_CR11","doi-asserted-by":"publisher","first-page":"105105","DOI":"10.1016\/j.bioorg.2021.105105","volume":"114","author":"K El-Adl","year":"2021","unstructured":"El-Adl, K. et al. Discovery of new quinoxaline-2 (1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorg. Chem. 114, 105105 (2021).","journal-title":"Bioorg. Chem."},{"key":"63591_CR12","doi-asserted-by":"publisher","first-page":"104380","DOI":"10.1016\/j.bioorg.2020.104380","volume":"105","author":"IH Eissa","year":"2020","unstructured":"Eissa, I. H. et al. Discovery of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorg. Chem. 105, 104380 (2020).","journal-title":"Bioorg. Chem."},{"issue":"12","key":"63591_CR13","doi-asserted-by":"publisher","first-page":"1900178","DOI":"10.1002\/ardp.201900178","volume":"352","author":"AA El-Helby","year":"2019","unstructured":"El-Helby, A. A., Sakr, H., Eissa, I. H., Al\u2010Karmalawy, A. A. & El\u2010Adl, K. Benzoxazole\/benzothiazole\u2010derived VEGFR\u20102 inhibitors: design, synthesis, molecular docking, and anticancer evaluations. Arch. Pharm. (Weinheim). 352 (12), 1900178 (2019).","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"63591_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fendo.2015.00159","volume":"6","author":"X Zhu","year":"2015","unstructured":"Zhu, X. & Zhou, W. The emerging regulation of VEGFR-2 in triple-negative breast cancer. Front. Endocrinol. (Lausanne). 6, 159 (2015).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"63591_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/biom14020153","volume":"14","author":"F Beierlein","year":"2024","unstructured":"Beierlein, F., Horn, A. H. C., Sticht, H., Mokhir, A. & Imhof, P. In Silico Study of Camptothecin-Based Pro-Drugs Binding to Human Carboxylesterase 2. Biomolecules 14 (2), 153 (2024).","journal-title":"Biomolecules"},{"issue":"1","key":"63591_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-022-01310-7","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy. J. Hematol. Oncol. 15 (1), 89 (2022).","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"63591_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd2130","volume":"5","author":"S Wilhelm","year":"2006","unstructured":"Wilhelm, S. et al. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat. Rev. Drug Discov. 5 (10), 835\u2013844 (2006).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"1","key":"63591_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1717002","volume":"379","author":"GK Abou-Alfa","year":"2018","unstructured":"Abou-Alfa, G. K. et al. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl. J. Med. 379 (1), 54\u201363 (2018).","journal-title":"N Engl. J. Med."},{"key":"63591_CR19","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zou, J. Y., Wang, Z. & Wang, Y. Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer. Cancer Manag Res. Published online 2019:7787\u20137803 .","DOI":"10.2147\/CMAR.S215533"},{"issue":"4","key":"63591_CR20","doi-asserted-by":"publisher","first-page":"e13009","DOI":"10.1111\/cpr.13009","volume":"54","author":"G Liu","year":"2021","unstructured":"Liu, G. et al. Inhibition of FGF-FGFR and VEGF\u2010VEGFR signalling in cancer treatment. Cell. Prolif. 54 (4), e13009 (2021).","journal-title":"Cell. Prolif."},{"key":"63591_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12859-019-2737-1","volume":"20","author":"W Liang","year":"2019","unstructured":"Liang, W., Zheng, Y., Zhang, J. & Sun, X. Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways. BMC Bioinform. 20, 59\u201371 (2019).","journal-title":"BMC Bioinform."},{"issue":"12","key":"63591_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrm4084","volume":"16","author":"A Akhmanova","year":"2015","unstructured":"Akhmanova, A. & Steinmetz, M. O. Control of microtubule organization and dynamics: two ends in the limelight. Nat. Rev. Mol. cell. Biol. 16 (12), 711\u2013726 (2015).","journal-title":"Nat. Rev. Mol. cell. Biol."},{"key":"63591_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/B978-0-12-407699-0.00002-9","volume":"302","author":"RF Ludue\u00f1a","year":"2013","unstructured":"Ludue\u00f1a, R. F. A hypothesis on the origin and evolution of tubulin. Int. Rev. Cell. Mol. Biol. 302, 41\u2013185 (2013).","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"63591_CR24","doi-asserted-by":"crossref","unstructured":"Knossow, M., Campanacci, V., Khodja, L. A. & Gigant, B. The mechanism of tubulin assembly into microtubules: insights from structural studies. Iscience 23(9). (2020).","DOI":"10.1016\/j.isci.2020.101511"},{"issue":"2","key":"63591_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1158\/1535-7163.MCT-13-0791","volume":"13","author":"E Mukhtar","year":"2014","unstructured":"Mukhtar, E., Adhami, V. M. & Mukhtar, H. Targeting microtubules by natural agents for cancer therapy. Mol. Cancer Ther. 13 (2), 275\u2013284 (2014).","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"63591_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2478\/aiht-2019-70-3258","volume":"70","author":"B Karahalil","year":"2019","unstructured":"Karahalil, B., Yard\u0131m-Akaydin, S. & Nacak Baytas, S. An overview of microtubule targeting agents for cancer therapy. Arh Hig Rada Toksikol. 70 (3), 160\u2013172 (2019).","journal-title":"Arh Hig Rada Toksikol"},{"issue":"4","key":"63591_CR27","doi-asserted-by":"publisher","first-page":"151075","DOI":"10.1016\/j.ejcb.2020.151075","volume":"99","author":"V \u010cerm\u00e1k","year":"2020","unstructured":"\u010cerm\u00e1k, V. et al. Microtubule-targeting agents and their impact on cancer treatment. Eur. J. Cell. Biol. 99 (4), 151075 (2020).","journal-title":"Eur. J. Cell. Biol."},{"issue":"18","key":"63591_CR28","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1016\/j.bmc.2014.02.035","volume":"22","author":"JJ Field","year":"2014","unstructured":"Field, J. J., Kanakkanthara, A. & Miller, J. H. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function. Bioorg. Med. Chem. 22 (18), 5050\u20135059 (2014).","journal-title":"Bioorg. Med. Chem."},{"key":"63591_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bioorg.2017.04.007","volume":"72","author":"SNA Bukhari","year":"2017","unstructured":"Bukhari, S. N. A., Kumar, G. B., Revankar, H. M. & Qin, H. L. Development of combretastatins as potent tubulin polymerization inhibitors. Bioorg. Chem. 72, 130\u2013147 (2017).","journal-title":"Bioorg. Chem."},{"issue":"15","key":"63591_CR30","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.4155\/fmc-2017-0100","volume":"9","author":"W Li","year":"2017","unstructured":"Li, W., Sun, H., Xu, S., Zhu, Z. & Xu, J. Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. Future Med. Chem. 9 (15), 1765\u20131794 (2017).","journal-title":"Future Med. Chem."},{"key":"63591_CR31","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","volume":"29","author":"Y Lu","year":"2012","unstructured":"Lu, Y., Chen, J., Xiao, M., Li, W. & Miller, D. D. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm. Res. 29, 2943\u20132971 (2012).","journal-title":"Pharm. Res."},{"key":"63591_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","volume":"87","author":"R Kaur","year":"2014","unstructured":"Kaur, R., Kaur, G., Gill, R. K., Soni, R. & Bariwal, J. Recent developments in tubulin polymerization inhibitors: an overview. Eur. J. Med. Chem. 87, 89\u2013124 (2014).","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"63591_CR33","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cells8091102","volume":"8","author":"J J\u00e1szai","year":"2019","unstructured":"J\u00e1szai, J. & Schmidt, M. H. H. Trends and challenges in tumor anti-angiogenic therapies. Cells 8 (9), 1102 (2019).","journal-title":"Cells"},{"key":"63591_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/156802662102201211113414","volume":"21","author":"J Su","year":"2021","unstructured":"Su, J., Zhu, H., liang, Yao, Y. & Duan, Y. Antiangiogenic therapy: challenges and future directions. Ctmc 21, 87\u201389 (2021).","journal-title":"Ctmc"},{"key":"63591_CR35","doi-asserted-by":"publisher","first-page":"113083","DOI":"10.1016\/j.ejmech.2020.113083","volume":"211","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1, 2, 3-triazole scaffold. Eur. J. Med. Chem. 211, 113083 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"63591_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2018.11.042","volume":"163","author":"X Pan","year":"2019","unstructured":"Pan, X. et al. Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1, 2, 3-triazol. Eur. J. Med. Chem. 163, 1\u20139 (2019).","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"63591_CR37","doi-asserted-by":"publisher","first-page":"e48290","DOI":"10.15252\/embr.201948290","volume":"21","author":"SM Ki","year":"2020","unstructured":"Ki, S. M. et al. CEP 41-mediated ciliary tubulin glutamylation drives angiogenesis through AURKA\u2010dependent deciliation. EMBO Rep. 21 (2), e48290 (2020).","journal-title":"EMBO Rep."},{"issue":"3","key":"63591_CR38","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.rpor.2020.04.004","volume":"25","author":"I Piotrowski","year":"2020","unstructured":"Piotrowski, I., Kulcenty, K. & Suchorska, W. Interplay between inflammation and cancer. Rep. Pract. Oncol. Radiother. 25 (3), 422\u2013427 (2020).","journal-title":"Rep. Pract. Oncol. Radiother"},{"issue":"1","key":"63591_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten, F. R. & Grivennikov, S. I. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51 (1), 27\u201341 (2019).","journal-title":"Immunity"},{"issue":"6","key":"63591_CR40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2010.03.006","volume":"140","author":"R Medzhitov","year":"2010","unstructured":"Medzhitov, R. Inflammation 2010: new adventures of an old flame. Cell 140 (6), 771\u2013776 (2010).","journal-title":"Cell"},{"issue":"4","key":"63591_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3390\/cancers11040564","volume":"11","author":"L Wu","year":"2019","unstructured":"Wu, L., Saxena, S., Awaji, M. & Singh, R. K. Tumor-associated neutrophils in cancer: going pro. Cancers (Basel). 11 (4), 564 (2019).","journal-title":"Cancers (Basel)"},{"issue":"7203","key":"63591_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454 (7203), 436\u2013444 (2008).","journal-title":"Nature"},{"issue":"7","key":"63591_CR43","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","volume":"30","author":"F Colotta","year":"2009","unstructured":"Colotta, F., Allavena, P., Sica, A., Garlanda, C. & Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30 (7), 1073\u20131081 (2009).","journal-title":"Carcinogenesis"},{"issue":"1","key":"63591_CR44","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/14756366.2021.1929201","volume":"36","author":"TS Ibrahim","year":"2021","unstructured":"Ibrahim, T. S. et al. Novel chalcone\/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction. J. Enzyme Inhib. Med. Chem. 36 (1), 1067\u20131078 (2021).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"11","key":"63591_CR45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.47102\/annals-acadmedsg.V38N11p960","volume":"38","author":"BL Sng","year":"2009","unstructured":"Sng, B. L. & Schug, S. A. The role of opioids in managing chronic non-cancer pain. Ann. Acad. Med. Singap. 38 (11), 960\u2013966 (2009).","journal-title":"Ann. Acad. Med. Singap."},{"issue":"11","key":"63591_CR46","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1016\/j.ejmech.2010.07.049","volume":"45","author":"XY Sun","year":"2010","unstructured":"Sun, X. Y. et al. Synthesis and anti-inflammatory activity evaluation of some novel 6-alkoxy (phenoxy)-[1, 2, 4] triazolo [3, 4-a] phthalazine-3-amine derivatives. Eur. J. Med. Chem. 45 (11), 4807\u20134812 (2010).","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"63591_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2710.2006.00754.x","volume":"31","author":"R Eccles","year":"2006","unstructured":"Eccles, R. Efficacy and safety of over-the\u2010counter analgesics in the treatment of common cold and flu. J. Clin. Pharm. Ther. 31 (4), 309\u2013319 (2006).","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"63591_CR48","first-page":"197","volume":"65","author":"DS Rashwan","year":"2022","unstructured":"Rashwan, D. S., El-deen, M. D., Nagy, R. A. & Elhakim, A. Green synthesis of zinc oxide Nanocomposite using Fusarium oxysporum and evaluation of the Anticancer Effect on Hepatocellular Carcinoma. Egypt. J. Chem. 65 (4), 197\u2013207 (2022).","journal-title":"Egypt. J. Chem."},{"issue":"2","key":"63591_CR49","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s13399-023-04827-0","volume":"15","author":"AM El-Khawaga","year":"2025","unstructured":"El-Khawaga, A. M. et al. Green synthesized ZnO nanoparticles by Saccharomyces cerevisiae and their antibacterial activity and photocatalytic degradation. Biomass Convers. Biorefinery. 15 (2), 2673\u20132684 (2025).","journal-title":"Biomass Convers. Biorefinery"},{"issue":"132","key":"63591_CR50","first-page":"1477","volume":"65","author":"AA Nagy","year":"2022","unstructured":"Nagy, A. A., Elhakim, R. K. A. & Mohamed, H. Anticancer effect of Sorafenib-loaded iron oxide nanoparticles and bee venom on some genes expression in hepatocellular carcinoma. Egypt. J. Chem. 65 (132), 1477\u20131487 (2022).","journal-title":"Egypt. J. Chem."},{"key":"63591_CR51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bioorg.2017.09.018","volume":"75","author":"AM Mohassab","year":"2017","unstructured":"Mohassab, A. M. et al. Novel quinoline incorporating 1, 2, 4-triazole\/oxime hybrids: synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations. Bioorg. Chem. 75, 242\u2013259 (2017).","journal-title":"Bioorg. Chem."},{"issue":"45","key":"63591_CR52","doi-asserted-by":"publisher","first-page":"13474","DOI":"10.1021\/ja0273750","volume":"124","author":"JL Sessler","year":"2002","unstructured":"Sessler, J. L., Maeda, H., Mizuno, T., Lynch, V. M. & Furuta, H. Quinoxaline-bridged porphyrinoids. J. Am. Chem. Soc. 124 (45), 13474\u201313479 (2002).","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"63591_CR53","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.2174\/1389557511313110007","volume":"13","author":"B Miniyar","year":"2013","unstructured":"Miniyar, B., Murumkar, P. R., Patil, P. S., Barmade, P. A. & Bothara, M. G. Unequivocal role of pyrazine ring in medicinally important compounds: A review. Mini Rev. Med. Chem. 13 (11), 1607\u20131625 (2013).","journal-title":"Mini Rev. Med. Chem."},{"issue":"2","key":"63591_CR54","first-page":"911","volume":"52","author":"A Katoh","year":"2000","unstructured":"Katoh, A., Yoshida, T. & Ohkanda, J. Synthesis of quinoxaline derivatives bearing the styryl and phenylethynyl groups and application to a fluorescence derivatization reagent. Heterocycles Int. J. Rev. Commun. Heterocycl. Chem. 52 (2), 911\u2013920 (2000).","journal-title":"Heterocycles Int. J. Rev. Commun. Heterocycl. Chem."},{"key":"63591_CR55","doi-asserted-by":"publisher","first-page":"590970","DOI":"10.3389\/fonc.2020.590970","volume":"10","author":"TJ Carneiro","year":"2020","unstructured":"Carneiro, T. J., Martins, A. S., Marques, M. P. M. & Gil, A. M. Metabolic aspects of palladium (II) potential anti-cancer drugs. Front. Oncol. 10, 590970 (2020).","journal-title":"Front. Oncol."},{"key":"63591_CR56","doi-asserted-by":"crossref","unstructured":"Scattolin, T., Voloshkin, V. A., Visentin, F. & Nolan, S. P. A critical review of palladium organometallic anticancer agents. Cell. Rep. Phys. Sci. 2(6). (2021).","DOI":"10.1016\/j.xcrp.2021.100446"},{"issue":"15","key":"63591_CR57","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.3390\/ijms22158271","volume":"22","author":"R Czarnomysy","year":"2021","unstructured":"Czarnomysy, R., Radomska, D., Szewczyk, O. K., Roszczenko, P. & Bielawski, K. Platinum and palladium complexes as promising sources for antitumor treatments. Int. J. Mol. Sci. 22 (15), 8271 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"63591_CR58","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s13738-015-0804-8","volume":"13","author":"EZ Jahromi","year":"2016","unstructured":"Jahromi, E. Z. et al. Palladium complexes: new candidates for anti-cancer drugs. J. Iran. Chem. Soc. 13, 967\u2013989 (2016).","journal-title":"J. Iran. Chem. Soc."},{"key":"63591_CR59","doi-asserted-by":"publisher","first-page":"115144","DOI":"10.1016\/j.inoche.2025.115144","volume":"181","author":"SS Hassan","year":"2025","unstructured":"Hassan, S. S., Sultan, M. A., Ismail, K. M. & Hassan, H. B. Boosted ethanol oxidation in alkaline media with 1D Pd-MOF for enhanced fuel cell performance. Inorg. Chem. Commun. 181, 115144 (2025).","journal-title":"Inorg. Chem. Commun."},{"key":"63591_CR60","doi-asserted-by":"crossref","unstructured":"Van Meerloo, J., Kaspers, G. J. L. & Cloos, J. Cell sensitivity assays: the MTT assay. Cancer cell. Cult. methods Protoc. Published online 2011:237\u2013245 .","DOI":"10.1007\/978-1-61779-080-5_20"},{"key":"63591_CR61","doi-asserted-by":"publisher","first-page":"105708","DOI":"10.1016\/j.bioorg.2022.105708","volume":"122","author":"MS Nafie","year":"2022","unstructured":"Nafie, M. S. & Boraei, A. T. A. Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer. Bioorg. Chem. 122, 105708 (2022).","journal-title":"Bioorg. Chem."},{"issue":"9","key":"63591_CR62","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1039\/D1NJ05655G","volume":"46","author":"MS Elgawish","year":"2022","unstructured":"Elgawish, M. S., Nafie, M. S., Yassen, A. S. A., Yamada, K. & Ghareb, N. The design and synthesis of potent benzimidazole derivatives via scaffold hybridization and evaluating their antiproliferative and proapoptotic activity against breast and lung cancer cell lines. New. J. Chem. 46 (9), 4239\u20134256 (2022).","journal-title":"New. J. Chem."},{"issue":"10","key":"63591_CR63","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/ph15101262","volume":"15","author":"T Al-Warhi","year":"2022","unstructured":"Al-Warhi, T., Sallam, A. & Ibrahim, M. Identification of novel cyanopyridones and pyrido [2, 3-D] pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies. Pharmaceuticals 15 (10), 1262 (2022).","journal-title":"Pharmaceuticals"},{"key":"63591_CR64","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bioorg.2018.06.003","volume":"80","author":"MS Abdelbaset","year":"2018","unstructured":"Abdelbaset, M. S. et al. Novel pyrrol-2 (3H)-ones and pyridazin-3 (2H)-ones carrying quinoline scaffold as anti-proliferative tubulin polymerization inhibitors. Bioorg. Chem. 80, 151\u2013163 (2018).","journal-title":"Bioorg. Chem."},{"issue":"1","key":"63591_CR65","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bmc.2016.10.040","volume":"25","author":"AG Ali","year":"2017","unstructured":"Ali, A. G., Mohamed, M. F., Abdelhamid, A. O. & Mohamed, M. S. A novel adamantane thiadiazole derivative induces mitochondria-mediated apoptosis in lung carcinoma cell line. Bioorg. Med. Chem. 25 (1), 241\u2013253 (2017).","journal-title":"Bioorg. Med. Chem."},{"issue":"21","key":"63591_CR66","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.4155\/bio-2021-0071","volume":"13","author":"A Nair","year":"2021","unstructured":"Nair, A. & Manohar, S. M. A flow cytometric journey into cell cycle analysis. Bioanalysis 13 (21), 1627\u20131644 (2021).","journal-title":"Bioanalysis"},{"issue":"11","key":"63591_CR67","doi-asserted-by":"publisher","first-page":"pdb","DOI":"10.1101\/pdb.prot087288","volume":"2016","author":"LC Crowley","year":"2016","unstructured":"Crowley, L. C., Marfell, B. J., Scott, A. P. & Waterhouse, N. J. Quantitation of apoptosis and necrosis by annexin V binding, propidium iodide uptake, and flow cytometry. Cold Spring Harb Protoc. 2016 (11), pdb\u2013prot087288 (2016).","journal-title":"Cold Spring Harb Protoc."},{"issue":"4","key":"63591_CR68","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. methods 25 (4), 402\u2013408 (2001).","journal-title":"methods"},{"key":"63591_CR69","doi-asserted-by":"crossref","unstructured":"Haidy, M. et al. Solima An integrated in vitro and in silico study to unveil the therapeutic potential of Chiliadenus montanus (Vahl) Brullo extract and extract-loaded chitosan nanoparticles against MDA-MB-231 breast cancer cells. J. Drug Deliv. Sci. Technol. 121. (2026).","DOI":"10.1016\/j.jddst.2026.108309"},{"issue":"2","key":"63591_CR70","first-page":"301","volume":"26","author":"C Ciniglia","year":"2010","unstructured":"Ciniglia, C., Pinto, G., Sansone, C. & Pollio, A. Acridine orange\/Ethidium bromide double staining test: A simple In-vitro assay to detect apoptosis induced by phenolic compounds in plant cells. Allelopath J. 26 (2), 301\u2013308 (2010).","journal-title":"Allelopath J."},{"key":"63591_CR71","unstructured":"Frisch, M. J. et al. Gaussian 16, Revision C. 01. Gaussian, Inc., There is no Corresp Rec this Ref. Published online 2023. (2016)."},{"key":"63591_CR72","doi-asserted-by":"publisher","first-page":"17336","DOI":"10.1038\/s41598-026-53122-1","volume":"16","author":"SS Hassan","year":"2026","unstructured":"Hassan, S. S., Dawood, K. M., Abubakr, A. S., Mahmoud, N. S. & Kheder, N. A. Synthesis, biological activities, DFT, and molecular docking of 1,3,4-thiadiazolo[2,3-c]-1,2,4-triazine-Palladium (II) complex. Sci. Rep. 16, 17336 (2026).","journal-title":"Sci. Rep."},{"issue":"1\u20133","key":"63591_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.molstruc.2005.09.010","volume":"786","author":"S Breda","year":"2006","unstructured":"Breda, S., Reva, I. D., Lapinski, L., Nowak, M. J. & Fausto, R. Infrared spectra of pyrazine, pyrimidine and pyridazine in solid argon. J. Mol. Struct. 786 (1\u20133), 193\u2013206 (2006).","journal-title":"J. Mol. Struct."},{"issue":"12","key":"63591_CR74","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1016\/j.electacta.2006.11.004","volume":"52","author":"KM Ismail","year":"2007","unstructured":"Ismail, K. M. Electrochemical preparation and kinetic study of poly(o-tolidine) in aqueous medium. Electrochim. Acta. 52 (12), 3883\u20133888 (2007).","journal-title":"Electrochim. Acta"},{"key":"63591_CR75","doi-asserted-by":"publisher","unstructured":"BenGuzzi, S. A., Abubakr, S. & Hassan, A. Structural and biological studies of mononuclear metal (II) complexes containing hetero ligand based on 3-acetylpyridine thiosemicarbazone. Appl. Organomet. Chem. 37 (9). https:\/\/doi.org\/10.1002\/aoc.7203 (2023).","DOI":"10.1002\/aoc.7203"},{"key":"63591_CR76","doi-asserted-by":"publisher","first-page":"137469","DOI":"10.1016\/j.cplett.2020.137469","volume":"751","author":"B Samir","year":"2020","unstructured":"Samir, B., Kalalian, C., Roth, E., Salghi, R. & Chakir, A. Gas-phase UV absorption spectra of pyrazine, pyrimidine and pyridazine. Chem. Phys. Lett. 751, 137469 (2020).","journal-title":"Chem. Phys. Lett."},{"issue":"9","key":"63591_CR77","doi-asserted-by":"publisher","first-page":"e6804","DOI":"10.1002\/aoc.6804","volume":"36","author":"SS Hassan","year":"2022","unstructured":"Hassan, S. S. et al. The dual therapeutic effect of metformin nuclei-based drugs modified with one of Tulbaghia violacea extract compounds. Appl. Organomet. Chem. 36 (9), e6804 (2022).","journal-title":"Appl. Organomet. Chem."},{"issue":"1","key":"63591_CR78","doi-asserted-by":"publisher","first-page":"e5258","DOI":"10.1002\/aoc.5258","volume":"34","author":"SS Hassan","year":"2020","unstructured":"Hassan, S. S. & Mohamed, E. F. Antimicrobial, antioxidant and antitumor activities of nano-structure Eu(III) and La(III) complexes with nitrogen donor tridentate ligands. Appl. Organomet. Chem. 34 (1), e5258 (2020).","journal-title":"Appl. Organomet. Chem."},{"key":"63591_CR79","doi-asserted-by":"publisher","first-page":"144954","DOI":"10.1016\/j.electacta.2024.144954","volume":"504","author":"KM Ismail","year":"2024","unstructured":"Ismail, K. M., Hassan, S. S., Medany, S. S. & Hefnawy, M. A. A novel Ni-complex nanocatalyst for efficient electrochemical oxidation of alcohol in alkaline medium: Mechanism and DFT study. Electrochim. Acta. 504, 144954 (2024).","journal-title":"Electrochim. Acta"},{"key":"63591_CR80","doi-asserted-by":"publisher","first-page":"101767","DOI":"10.1016\/j.rechem.2024.101767","volume":"11","author":"HA El-Boraey","year":"2024","unstructured":"El-Boraey, H. A., El-Ghnam, H., Atia, E. M. & Hassan, S. S. Designing of some VO (II), Co (II) and Hg (II) Schiff base complexes: Synthesis, structure elucidation, anticancer and biopesticidal activities, DFT and docking approaches. Results Chem. 11, 101767 (2024).","journal-title":"Results Chem."},{"issue":"12","key":"63591_CR81","doi-asserted-by":"publisher","first-page":"e7713","DOI":"10.1002\/aoc.7713","volume":"38","author":"SS Hassan","year":"2024","unstructured":"Hassan, S. S., Hosny, W. M., Aboutabl, M. A., Fayed, D. B. & Khalf-Alla, P. A. Comparison of In Vitro and In Vivo Biological Screening of Nano\u2010Palladium (II) and Platinum (II)\u2010Based Compounds With DFT and Molecular Docking Study. Appl. Organomet. Chem. 38 (12), e7713 (2024).","journal-title":"Appl. Organomet. Chem."},{"key":"63591_CR82","unstructured":"Pyrazine (C\u2084H\u2084N2), \u00b9H NMR spectrum (300\u00a0MHz, CDCl\u2083), ChemicalBook. Retrieved March 2. from (2026). https:\/\/www.chemicalbook.com\/SpectrumEN_290-37-9_1HNMR.htm."},{"key":"63591_CR83","doi-asserted-by":"publisher","first-page":"108965","DOI":"10.1016\/j.surfin.2026.108965","volume":"87","author":"KM Ismail","year":"2026","unstructured":"Ismail, K. M., Hassan, S. S., Harb, A. H. A., Salah, A. M. & Elewa, A. M. Design and application of zinc-based metal-organic framework for ^152 + 154Eu(III) adsorption: Experimental and DFT insights. Surf. Interfaces. 87, 108965 (2026).","journal-title":"Surf. Interfaces"},{"issue":"Pt 2","key":"63591_CR84","doi-asserted-by":"publisher","first-page":"132691","DOI":"10.1016\/j.ijbiomac.2024.132691","volume":"271","author":"SH El-Taweel","year":"2024","unstructured":"El-Taweel, S. H., Hassan, S. S. & Ismail, K. M. Eco-friendly zinc-metal-organic framework as a nucleating agent for poly(lactic acid). Int. J. Biol. Macromol. 271 (Pt 2), 132691 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"63591_CR85","doi-asserted-by":"publisher","first-page":"189336","DOI":"10.1016\/j.jallcom.2026.189336","volume":"1076","author":"AMA Elsayed","year":"2026","unstructured":"Elsayed, A. M. A. et al. nSi@MIL-53(Al) anode for lithium-ion batteries with incessantly improved capacity enabled by its structure-activation, and Li\u207a-enriching characteristics. J. Alloys Compd. 1076, 189336 (2026).","journal-title":"J. Alloys Compd."},{"issue":"1","key":"63591_CR86","doi-asserted-by":"publisher","first-page":"e7908","DOI":"10.1002\/aoc.7908","volume":"39","author":"KM Ismail","year":"2025","unstructured":"Ismail, K. M., Hassan, S. S. & Hanna, D. H. Palladium-Imidazole Nanoparticles\u2019 Cytotoxic Effects on Colon Cancer Cells: Induction of Cell Cycle Arrest and Apoptosis Mediated via Mitochondria. Appl. Organomet. Chem. 39 (1), e7908 (2025).","journal-title":"Appl. Organomet. Chem."},{"key":"63591_CR87","doi-asserted-by":"publisher","first-page":"121903","DOI":"10.1016\/j.ica.2023.121903","volume":"563","author":"TI Kashar","year":"2024","unstructured":"Kashar, T. I., Hassan, S. S. & El-Boraey, H. A. Spectroscopic inspection, DFT analysis, biological evaluation and molecular docking studies of new 2-(phenylamino) acetohydrazide hydrazone based-transition metal complexes. Inorganica Chim. Acta. 563, 121903 (2024).","journal-title":"Inorganica Chim. Acta"},{"key":"63591_CR88","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ijhydene.2024.12.335","volume":"100","author":"MA Sultan","year":"2025","unstructured":"Sultan, M. A., Hassan, H. B., Hassan, S. S. & Ismail, K. M. Enhanced electrocatalytic alcohol oxidation with Ni-MOF for direct alcohol fuel cell applications. Int. J. Hydrogen Energy. 100, 528\u2013547 (2025).","journal-title":"Int. J. Hydrogen Energy"},{"issue":"4","key":"63591_CR89","first-page":"149","volume":"53","author":"S Gunasekaran","year":"2008","unstructured":"Gunasekaran, S., Balaji, R. A., Kumeresan, S., Anand, G. & Srinivasan, S. Experimental and theoretical investigations of spectroscopic properties of N-acetyl-5-methoxytryptamine. Can. J. Anal. Sci. Spectrosc. 53 (4), 149\u2013162 (2008).","journal-title":"Can. J. Anal. Sci. Spectrosc."},{"issue":"6","key":"63591_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers17060958","volume":"17","author":"I Buyukgolcigezli","year":"2025","unstructured":"Buyukgolcigezli, I., Tenekeci, A. K. & Sahin, I. H. Opportunities and challenges in antibody\u2013drug conjugates for cancer therapy: a new era for cancer treatment. Cancers 17 (6), 1\u201320. https:\/\/doi.org\/10.3390\/cancers17060958 (2025).","journal-title":"Cancers"},{"key":"63591_CR91","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41598-024-81294-1","volume":"15","author":"MI Shosha","year":"2025","unstructured":"Shosha, M. I., El-Ablack, F. Z. & Saad, E. A. New thiazole derivative as a potential anticancer and topoisomerase II inhibitor. Sci. Rep. 15, 710 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"63591_CR92","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","volume":"15","author":"J MacMicking","year":"1997","unstructured":"MacMicking, J., Xie, Q. & wen, N. C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1), 323\u2013350 (1997).","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"63591_CR93","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/med.20092","volume":"27","author":"S Mocellin","year":"2007","unstructured":"Mocellin, S., Bronte, V. & Nitti, D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med. Res. Rev. 27 (3), 317\u2013352 (2007).","journal-title":"Med. Res. Rev."},{"issue":"4","key":"63591_CR94","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrd3358","volume":"10","author":"J Leiper","year":"2011","unstructured":"Leiper, J. & Nandi, M. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat. Rev. Drug Discov. 10 (4), 277\u2013291 (2011).","journal-title":"Nat. Rev. Drug Discov"},{"key":"63591_CR95","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/A:1005912906436","volume":"17","author":"LL Thomsen","year":"1998","unstructured":"Thomsen, L. L. & Miles, D. W. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev. 17, 107\u2013118 (1998).","journal-title":"Cancer Metastasis Rev."},{"key":"63591_CR96","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.1016\/j.semcancer.2015.09.007","volume":"35","author":"KI Block","year":"2015","unstructured":"Block, K. I. et al. A broad-spectrum integrative design for cancer prevention and therapy. Sem. Cancer Biol. 35, S276 (2015).","journal-title":"Sem. Cancer Biol."},{"key":"63591_CR97","doi-asserted-by":"crossref","unstructured":"Chiang, S. R., Lin, C. S. & Lin, H. H. Pel-Chen Shieh and Shao-Hsuan Kao. Bergapten induces G1 arrest of non-small cell lung cancer cells, associated with the p53-mediated cascade. Mol. Med. Rep. 19, 1972\u20131978 (2019).","DOI":"10.3892\/mmr.2019.9810"},{"issue":"3","key":"63591_CR98","doi-asserted-by":"publisher","first-page":"pdb","DOI":"10.1101\/pdb.prot4493","volume":"2006","author":"S Kasibhatla","year":"2006","unstructured":"Kasibhatla, S. et al. Acridine orange\/ethidium bromide (AO\/EB) staining to detect apoptosis. Cold Spring Harb Protoc. 2006 (3), pdb\u2013prot4493 (2006).","journal-title":"Cold Spring Harb Protoc."},{"issue":"24","key":"63591_CR99","doi-asserted-by":"publisher","first-page":"e202200480","DOI":"10.1002\/cmdc.202200480","volume":"17","author":"R Liang","year":"2022","unstructured":"Liang, R., Liu, N. & Li, F. Recent advances of anticancer studies based on nano-fluorescent metal-organic frameworks. ChemMedChem 17 (24), e202200480. https:\/\/doi.org\/10.1002\/cmdc.202200480 (2022).","journal-title":"ChemMedChem"},{"key":"63591_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s10904-026-04200-4","author":"NB Mohager","year":"2026","unstructured":"Mohager, N. B. et al. Pyrazine-Platinum (II) nanoparticles as a potential anticancer agent: Synthesis, binding mechanisms, and biological profiling. J. Inorg. Organomet. Polym. Mater. https:\/\/doi.org\/10.1007\/s10904-026-04200-4 (2026).","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"63591_CR101","doi-asserted-by":"publisher","first-page":"17336","DOI":"10.1038\/s41598-026-53122-1","volume":"16","author":"SS Hassan","year":"2026","unstructured":"Hassan, S. S., Dawood, K. M., Abubakr, A. S., Mahmoud, N. S. & Kheder, N. A. Synthesis, biological activities, DFT, and molecular docking of 1,3,4-thiadiazolo[2,3-c]-1,2,4-triazine-Palladium (II) complex. Sci. Rep. 16, 17336. https:\/\/doi.org\/10.1038\/s41598-026-53122-1 (2026).","journal-title":"Sci. Rep."},{"key":"63591_CR102","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12951-022-01395-9","volume":"20","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Two-dimensional metal-organic frameworks: From synthesis to bioapplications. J. Nanobiotechnol. 20, 207 (2022).","journal-title":"J. Nanobiotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63591-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63591-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63591-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:03:48Z","timestamp":1785474228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63591-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63591"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63591-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23653"}}